About

We want to develop innovative and effective forms of supportive and integrated care to reduce toxicity and improve tolerability of therapy.


Research group leader

prof. dr. Nicole Blijlevens

contact form

Aims

See our most important goals.

read more

Aims

  • Prevention or treatment of mucosal barrier injury and induced inflammatory complications like mucositis, infections and graft versus host disease (GvHD)
  • To increase drug adherence and improve tolerability of oral cancer therapy
  • To promote self-management and fitness as a person living with chronic malignant diseases



Publications

See some of our most important scientific articles.

read more

Publications